Hit enter to search or ESC to close

Analyst Coverage


MST Access

Benchmark Company


Rosemary Cummins

Robert Wasserman

Alterity Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Alterity Therapeutics’ performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Alterity Therapeutics or its management. Alterity Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Receive news from Alterity Therapeutics